XTL Biopharmaceuticals Ltd ADR Long-term Investment Intensity
XTL Biopharmaceuticals Ltd ADR long-term investment intensity. XTL Biopharmaceuticals Ltd ADR (XTLB) has a Long-term Investment Intensity of 2.0% as of June 2025. Long-term investments of $14.00K represent 2.0% of total assets of $714.00K. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read XTLB current and long-term liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of XTL Biopharmaceuticals Ltd ADR (2024–2024)
Long-term investment intensity of XTL Biopharmaceuticals Ltd ADR from 2024 to 2024. This chart shows how XTL Biopharmaceuticals Ltd ADR's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of June 2025, the intensity stands at 2.0%, reflecting long-term investments of $14.00K against total assets of $714.00K USD.
XTL Biopharmaceuticals Ltd ADR Long-term Investment Intensity by Year (2024–2024)
XTL Biopharmaceuticals Ltd ADR long-term investment intensity by year from 2024 to 2024. The table below presents the year-by-year Long-term Investment Intensity for XTL Biopharmaceuticals Ltd ADR from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see XTLB total asset value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.2% | $14.00K | $8.55 Million | — |